Mirai Medical announced that it secured approximately $8.4 million (€7.2 million) in funding from the Irish government.
The Galway-based company earned its funding through the country’s Disruptive Technologies Innovation Fund (DTIF) Call 7 for its PIONEER technology — Pathology and Immuno-Oncology with Next-Generation Screening and Electroporation for Enhanced Response.